Literature DB >> 7738546

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.

R Midgard1, G Albrektsen, T Riise, G Kvåle, H Nyland.   

Abstract

A longitudinal, population based study of life expectancy in multiple sclerosis was performed in the county of Møre and Romsdal, Norway during the period 1950-84. A total of 251 patients with multiple sclerosis (110 men, 141 women, mean age at onset of disease 33.6 years) were included. The mean follow up time was 18.1 years. At the end of the study period 70 patients had died. Fifty four (77.1%) of these had multiple sclerosis as the underlying or contributing cause of death on the death certificates. Young age at onset, initial remitting clinical course, and the presence of sensory symptoms at onset were significantly associated with longer survival.

Entities:  

Mesh:

Year:  1995        PMID: 7738546      PMCID: PMC1073425          DOI: 10.1136/jnnp.58.4.417

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Lethality, duration, and mortality of disseminated sclerosis in Denmark.

Authors:  K Hyllested
Journal:  Acta Psychiatr Scand       Date:  1961       Impact factor: 6.392

2.  Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population.

Authors:  R Midgard; T Riise; H Nyland
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

3.  The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

Authors:  B G Weinshenker; G P Rice; J H Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1991-04       Impact factor: 13.501

4.  Survival and death in multiple sclerosis.

Authors:  U Leibowitz; E Kahana; M Alter
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

5.  Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.

Authors:  T Riise; M Grønning; J A Aarli; H Nyland; J P Larsen; A Edland
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

6.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

Authors:  B Runmarker; O Andersen
Journal:  Brain       Date:  1993-02       Impact factor: 13.501

7.  Factors associated with a malignant or benign course of multiple sclerosis.

Authors:  V A Clark; R Detels; B R Visscher; N L Valdiviezo; R M Malmgren; J P Dudley
Journal:  JAMA       Date:  1982-08-20       Impact factor: 56.272

8.  Onset symptoms as predictors of mortality and disability in multiple sclerosis.

Authors:  B R Visscher; K S Liu; V A Clark; R Detels; R M Malmgren; J P Dudley
Journal:  Acta Neurol Scand       Date:  1984-11       Impact factor: 3.209

9.  A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota.

Authors:  D R Wynn; M Rodriguez; W M O'Fallon; L T Kurland
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

10.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

Authors:  C Confavreux; G Aimard; M Devic
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  11 in total

Review 1.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 2.  Clinical prognostic factors in multiple sclerosis: a natural history review.

Authors:  Alexandra Degenhardt; Sreeram V Ramagopalan; Antonio Scalfari; George C Ebers
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

3.  Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway.

Authors:  Ola Nakken; Jonas Christoffer Lindstrøm; Trygve Holmøy
Journal:  J Neurol       Date:  2018-03-21       Impact factor: 4.849

4.  Impairment, disability, and handicap in multiple sclerosis. A cross-sectional study in an incident cohort in Møre and Romsdal County, Norway.

Authors:  R Midgard; T Riise; H Nyland
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

Review 5.  Mortality in patients with multiple sclerosis.

Authors:  Antonio Scalfari; Volker Knappertz; Gary Cutter; Douglas S Goodin; Raymond Ashton; George C Ebers
Journal:  Neurology       Date:  2013-07-09       Impact factor: 9.910

Review 6.  Painful and involuntary multiple sclerosis.

Authors:  Francesca Bagnato; Diego Centonze; Simonetta Galgani; Maria Grazia Grasso; Shalom Haggiag; Stefano Strano
Journal:  Expert Opin Pharmacother       Date:  2011-02-17       Impact factor: 3.889

7.  The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease.

Authors:  Lidia Karabon; Agata Kosmaczewska; Malgorzata Bilinska; Edyta Pawlak; Lidia Ciszak; Anna Jedynak; Anna Jonkisz; Leszek Noga; Anna Pokryszko-Dragan; Magdalena Koszewicz; Irena Frydecka
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

8.  Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry.

Authors:  N Koch-Henriksen; H Brønnum-Hansen; E Stenager
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

9.  Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.

Authors:  Hanne Marie Bøe Lunde; Jörg Assmus; Kjell-Morten Myhr; Lars Bø; Nina Grytten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04-01       Impact factor: 10.154

10.  The impact of multiple sclerosis onset symptom on cardiac repolarization.

Authors:  Alma Mikkola; Aku Ojanen; Juha E K Hartikainen; Anne M Remes; Sakari Simula
Journal:  Brain Behav       Date:  2017-06-05       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.